MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, SNSE had -$1,326K decrease in cash & cash equivalents over the period. -$20,469K in free cash flow.

Cash Flow Overview

Change in Cash
-$1,326K
Free Cash flow
-$20,469K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of short-term investm...
    • Non-cash lease expense
    • Stock-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Purchases of short-term investme...
    • Net loss
    • Operating lease liabilities
    • Others

Cash Flow
2025-12-31
Net loss
-21,085
Stock-based compensation expense
1,274
Depreciation and amortization
122
Accretion on marketable securities
-699
Impairment of financing right-of-use asset assets
0
Impairment of equipment
0
Non-cash lease expense
1,510
Amortization of financing lease right-of-use assets
17
Prepaid expenses
-243
Other assets
-80
Accounts payable and accrued liabilities
233
Compensation and employee benefits
-562
Operating lease liabilities
-1,586
Other liabilities
0
Net cash used in operating activities
-20,453
Purchases of property and equipment
16
Purchases of short-term investments
25,155
Maturities of short-term investments
44,693
Proceeds from sale of property and equipment
250
Net cash provided by investing activities
19,772
Principal payments for financing leases
790
Proceeds from the sale of financing lease assets
142
Payment of employee restricted stock tax withholdings
3
Employee stock purchase plan proceeds
5
Cash in lieu of fractional shares for reverse stock split
1
Exercise of options into common stock
2
Net cash used in financing activities
-645
Net decrease in cash and cash equivalents
-1,326
Cash and cash equivalents at beginning of period
9,994
Cash and cash equivalents at end of period
8,668
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Maturities of short-terminvestments$44,693K Proceeds from sale ofproperty and equipment$250K Net cash provided byinvesting activities$19,772K Canceled cashflow$25,171K Net decrease in cashand cash...-$1,326K Canceled cashflow$19,772K Non-cash lease expense$1,510K Stock-based compensationexpense$1,274K Prepaid expenses-$243K Accounts payable andaccrued liabilities$233K Depreciation andamortization$122K Other assets-$80K Amortization of financinglease right-of-use...$17K Proceeds from the sale offinancing lease assets$142K Employee stock purchaseplan proceeds$5K Exercise of options intocommon stock$2K Purchases of short-terminvestments$25,155K Purchases of property andequipment$16K Net cash used inoperating activities-$20,453K Canceled cashflow$3,479K Net cash used infinancing activities-$645K Canceled cashflow$149K Net loss-$21,085K Operating leaseliabilities-$1,586K Accretion on marketablesecurities-$699K Compensation and employeebenefits-$562K Principal payments forfinancing leases$790K Payment of employeerestricted stock tax...$3K Cash in lieu offractional shares for...$1K

Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics, Inc. (SNSE)